Evidence map›Paper›PMID 40164713›Full record

ArticleScientific reports2025

Mechanistic insights into the P-coumaric acid protection against bisphenol A-induced hepatotoxicity in in vivo and in silico models.

Samet Tekin, Merve Bolat, Aslıhan Atasever, İsmail Bolat, Burak Çinar, Azizeh Shadidizaji, Yusuf Dağ, Emin Şengül, Serkan Yildirim, Ahmet Hacimuftuoglu and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Development of Wedelia (Current issues in molecular biology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Samet TekinDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey. samet.tekin@atauni.edu.tr.
Merve BolatDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Aslıhan AtaseverDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
İsmail BolatDepartment of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Burak ÇinarDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Azizeh ShadidizajiDepartment of Plant Biotechnology, Faculty of Agriculture, Ataturk University, Erzurum, Turkey.
Yusuf DağDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Emin ŞengülDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Serkan YildirimDepartment of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Ahmet HacimuftuogluDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Mohamad WardaDepartment of Physiology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisphenol A (BPA), commonly found in plastic containers and epoxy resins used for food products, presents substantial health risks, particularly in relation to hepatic toxicity. This study investigates BPA-induced liver damage and explores the mechanistic dose-dependent protective effects of P-coumaric acid (PCA). 50 male rats were divided into control, BPA-treated, BPA + PCA50, BPA + PCA100, and PCA100 groups. BPA exposure for 14 days induced oxidative stress, evidenced by elevated malondialdehyde levels and decreased activities of antioxidant enzymes (superoxide dismutase, glutathione peroxidase, and catalase). Higher doses of PCA effectively mitigated these effects by restoring redox balance and enhancing antioxidant enzyme activities. Additionally, BPA disrupted inflammation and apoptosis pathways, inhibiting anti-inflammatory markers and interfering with the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) pathway. PCA exhibited dose-dependent protection against these disruptions. Computational analyses revealed that BPA inhibits cyclooxygenase-1 through stable hydrogen bonding with threonine at position 322. PCA's dual protective effect was confirmed by attenuating inflammatory pathways, including TNF-α inhibition and suppression of the Kelch-like ECH-associated protein 1 (KEAP1) and Nrf2 signaling pathway. Histopathological assessments confirmed that PCA alleviated significant hepatic damage induced by BPA. Immunohistochemical and immunofluorescence analyses further supported PCA's protective role against BPA-induced apoptosis and cellular hepatotoxicity. These findings underscore PCA's protective potential against BPA-induced hepatotoxicity and highlight novel mechanistic interactions that warrant further investigation in applied nutritional biochemistry.

Indexed as

Bisphenol A CompoundsChemical and Drug Induced Liver InjuryCoumaric AcidsMolecular Docking SimulationAnimalsApoptosisBody WeightHepatitisLiverMaleRatsbisphenol ABisphenol A CompoundsCoumaric Acidsp-coumaric acidApoptosisBisphenol AInflammationIn silicoOxidative stressP-Coumaric acid

Identifiers

PMID40164713
PMCPMC11958805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.